SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-179065
Filing Date
2020-06-25
Accepted
2020-06-25 16:16:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d944392dsc13d.htm SC 13D 46833
  Complete submission text file 0001193125-20-179065.txt   48213
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89959 | Film No.: 20989441
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PFENEX INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Wagner Paul A. (Filed by) CIK: 0001612842 (see all company filings)

Type: SC 13D